Diana F Clarke, Assistant Professor of Paediatrics at Boston University School of Medicine and Lead Investigator of the ...

Clinical trials are becoming increasingly complex. In a 2023 survey, 70% of investigative site staff said conducting studies ...

Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, marking the start of a ...

Hi, this project/product/partnership is going live next week – can you do some comms?’ ...

The introduction of oral GLP-1 medicines, alongside growing awareness of injectable treatments such as Wegovy and Mounjaro, ...

The UK approval of once-daily oral Wegovy is a significant moment for obesity treatment. For the first time, patients can ...

Reducing variation, preventing complications, supporting care ...

IMAAVY has become the first FDA‑approved therapy for warm autoimmune haemolytic anaemia, offering a targeted approach ...

A July 2026 Leerink Partners report named Carterra a core enabling technology in the growing Lab‑in‑the‑Loop market. The ...

GSK has announced that the US FDA has accepted for priority review a supplemental Biologics License Application for Jemperli ...

Nxera Pharma has announced that its partner Neurocrine Biosciences has received FDA IND acceptance for a phase 2 study of NBI‑1117567 for Alzheimer’s cognition. Nxera will rec ...

This month's mag takes the relentless tittle-tattle from 'influencers' about GLP-1 before scrutinizing, deconstructing and ...